Tuesday, 5 November 2019

Questions (442)

Alan Kelly


442. Deputy Alan Kelly asked the Minister for Health the volume of uptake of biosimilar prescribing under the best value biologic process by the HSE to date in 2019; the number of patients prescribed biosimilars by treatment type to date in 2019; the average savings per patient compared to the originator drugs; and if he will make a statement on the matter. [44252/19]

View answer

Written answers (Question to Health)

As this is an operational matter it has been referred to the Health Service Executive for direct reply to the Deputy.